Back to search
Skin Angiosarcoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Skin Angiosarcoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Skin Angiosarcoma trials you may qualify forThe purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which ty…
AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 effects and safety at various d…
Participants of this study will have a diagnosis of a solid tumor cancer that has come back to its original location or spread beyond its original location (adv…
Cutaneous angiosarcoma is a rare cancer for which effective treatment has not been developed sufficiently. Still, because it often occurs in elderly people, the…
This phase II trial studies how well paclitaxel with and without nivolumab works in treating patients with soft tissue sarcoma that have not received taxane dru…
To find the highest tolerable dose of an mRNA vaccine that can be safely given to patients with cutaneous angiosarcoma
Angiosarcoma is a rare and aggressive form of soft tissue sarcoma. Prior work demonstrates very poor outcomes, with most patients developing metastatic disease…